Paper Title : DEEP LEARNING PREDICTION OF ADVERSE DRUG REACTION ANALYSIS USING ARTIFICIAL NEURAL NETWORK MODEL

ISSN : 2394-2231
Year of Publication : 2022

10.5281/zenodo.6410024

Authors: Mrs. K.E. Eswari, M.C.A., M.Phil., M.E., SET., R. Sarathkumar

         



MLA Style: DEEP LEARNING PREDICTION OF ADVERSE DRUG REACTION ANALYSIS USING ARTIFICIAL NEURAL NETWORK MODEL " Mrs. K.E. Eswari, M.C.A., M.Phil., M.E., SET., R. Sarathkumar " Volume 9 - Issue 2 International Journal of Computer Techniques (IJCT) ,ISSN:2394-2231 , www.ijctjournal.org

APA Style: DEEP LEARNING PREDICTION OF ADVERSE DRUG REACTION ANALYSIS USING ARTIFICIAL NEURAL NETWORK MODEL " Mrs. K.E. Eswari, M.C.A., M.Phil., M.E., SET., R. Sarathkumar " Volume 9 - Issue 2 International Journal of Computer Techniques (IJCT) ,ISSN:2394-2231 , www.ijctjournal.org

Abstract
In medical domain, Adverse Drug Reaction (ADR) analysis is a crucial process for doctors and medical scientists.Adverse drug reaction measures the injury occurred due to usage of a drug. The growing concern to the ADRs hasstimulated the progress of statistical, data mining methods to find the Adverse Drug Reactions. This project proposed ahybrid model of data mining and machine learning to classify different Adverse Reactions and foretell the outcomeintensity. It used the Proportionality Reporting Ratio (PRR) along with ChiSquare test equations to find out the different relationships between drug and symptoms called the drugADR association. In addition, support vector machine method is applied to classify the data set records into either normal or adverse drug. Moreover, our project aims in finding the percent of adversity of the drug reaction. Based on the number of occurrences, where a specific drug P, causes a specific Adverse Reaction, R, the various terms are measured for PRR and Chi Square. In addition KNN andSVM classification is made on drug records to classify them based on data set columns. Neural network based classification is the proposed system to classify drug reaction based on data set columns.

Reference
[1] J. Nebeker, P. Barach and M. Samore, "Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting", Annals of Internal Medicine, vol. 140, no. 10, p. 795, 2004. [2] T. Huynh, Y. He, A. Willis and S. R¨uger, "Adverse Drug Reaction ClassificationWith Deep Neural Networks", in Proceedings of COLING 2016, the 26th International Conference on Computational Linguistics: Technical Papers, Osaka, Japan, 2016, pp. 877-887. [3] Y. Liu and U. Aickelin, "Detect adverse drug reactions for drug Pioglitazone", 2012 IEEE 11th International Conference on Signal Processing, 2012. [4] L. Duan, M. Khoshneshin, W. Street and M. Liu, "Adverse Drug Effect Detection", IEEE Journal of Biomedical and Health Informatics, vol. 17, no. 2, pp. 305- 311, 2013. [5] A. Tripathy, N. Joshi, H. Kale, M. Durando and L. Carvalho, "Detection of adverse drug events through data mining techniques", in 2015 International Conference on Technologies for Sustainable Development (ICTSD), Mumbai, India, 2015, pp. 01-06. [6] Ross SD. Drug-related adverse events: a readers’ guide to assessing literature reviewsandmetaanalyses.ArchInternMed.2001;161:1041- 6.[PMID:11322836] [7] Shojania KG, Duncan BW, McDonald KM, Wachter RM. Safe but sound: patient safety meets evidence-based medicine [Editorial]. JAMA. 2002;288:50813. [PMID: 12132985] [8] Kohn LT, Corrigan JM, Donaldson MS. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Pr; 1999. [9] Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274:29-34. [PMID: 7791255] [10] Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-64. [PMID: 12700376] [11] Fattinger K, Roos M, Vergeres P, Holenstein C, Kind B, Masche U, et al. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol. 2000;49:158-67. [PMID: 10671911] [12] Beatrice A. Golomb, John J. McGraw, Marcella A. Evans and Joel E. Dimsdale. Physician Response to Patient Reportsof Adverse Drug EffectsImplications For Patient-Targeted AdverseEffect Surveillance. Drug Safety 2007; 30 (8): 669-675. 0114-5916/07/0008-0669/$44.95/0. © 2007 Adis Data Information BV.

Keywords
— Adverse Drug Reaction, Proportionality Reporting Ratio, Chi Square, Neural Network